Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 78.65
+0.95 (1.22%)
Aug 7, 2026, 2:50 PM CET
Pharma Mar Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,347 | 1,298 | 1,400 | 725 | 1,164 | 1,027 | |
Market Cap Growth | -4.60% | -7.28% | 93.23% | -37.76% | 13.37% | -21.20% |
Enterprise Value | 1,224 | 1,180 | 1,297 | 605.76 | 1,022 | 874.44 |
Last Close Price | 78.65 | 74.90 | 79.80 | 41.08 | 64.30 | 57.02 |
PE Ratio | 24.97 | 17.42 | 53.56 | 684.67 | 23.55 | 11.12 |
Forward PE | 18.18 | 24.03 | 36.29 | 67.76 | 16.74 | 12.76 |
PEG Ratio | 0.87 | 0.09 | 0.33 | 2.22 | 26.93 | 5.37 |
PS Ratio | 6.16 | 5.86 | 4.00 | 4.58 | 3.24 | 4.47 |
PB Ratio | 5.37 | 5.16 | 6.72 | 3.75 | 2.02 | 5.77 |
P/TBV Ratio | 5.53 | 5.27 | 6.76 | 3.84 | 2.02 | 5.90 |
P/FCF Ratio | 24.94 | 27.82 | - | - | 39.51 | 32.17 |
P/OCF Ratio | 21.65 | 24.44 | 232.33 | - | 30.38 | 26.89 |
EV/Sales Ratio | 5.60 | 5.33 | 3.71 | 3.83 | 2.84 | 3.80 |
EV/EBITDA Ratio | 17.81 | 17.17 | 45.12 | - | 15.08 | 9.19 |
EV/EBIT Ratio | 20.16 | 19.44 | 59.04 | - | 16.51 | 9.46 |
EV/FCF Ratio | 22.66 | 25.30 | - | - | 34.68 | 27.40 |
Debt / Equity Ratio | 0.15 | 0.15 | 0.20 | 0.15 | 0.04 | 0.20 |
Debt / EBITDA Ratio | 0.72 | 0.72 | 1.78 | - | 0.50 | 0.52 |
Debt / FCF Ratio | 1.10 | 1.06 | - | - | 1.15 | 1.55 |
Net Debt / Equity Ratio | -0.47 | -0.47 | -0.50 | -0.61 | -0.25 | -0.86 |
Net Debt / EBITDA Ratio | -1.71 | -1.71 | -3.60 | 227.76 | -2.10 | -1.60 |
Net Debt / FCF Ratio | -2.63 | -2.52 | 11.51 | 11.78 | -4.83 | -4.78 |
Asset Turnover | 1.06 | 0.59 | 1.01 | 0.40 | 0.87 | 0.66 |
Inventory Turnover | 0.21 | 0.23 | 0.24 | 0.29 | 0.65 | 1.46 |
Quick Ratio | 2.43 | 2.43 | 2.38 | 2.19 | 2.51 | 2.93 |
Current Ratio | 3.02 | 3.02 | 3.03 | 2.63 | 2.87 | 3.42 |
Return on Equity (ROE) | 32.59% | 32.59% | 20.02% | 0.30% | 15.64% | 66.18% |
Return on Assets (ROA) | 20.50% | 20.50% | 10.86% | 0.30% | 15.24% | 25.83% |
Return on Invested Capital (ROIC) | 56.95% | 63.89% | 41.77% | 0.47% | 27.33% | - |
Return on Capital Employed (ROCE) | 21.37% | 21.37% | 8.59% | -1.26% | 19.21% | 35.74% |
Earnings Yield | 4.17% | 5.74% | 1.87% | 0.15% | 4.25% | 9.00% |
FCF Yield | 4.01% | 3.59% | - | - | 2.53% | 3.11% |
Dividend Yield | 1.29% | 1.07% | 0.82% | 1.59% | 1.01% | 1.06% |
Payout Ratio | - | 18.60% | 28.39% | 1028.06% | 19.95% | 11.71% |
Buyback Yield / Dilution | -3.57% | 0.62% | 1.98% | 0.81% | 0.12% | 1.31% |
Total Shareholder Return | -2.28% | 1.69% | 2.79% | 2.40% | 1.13% | 2.36% |